UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Coastline Trust Co

Coastline Trust Co lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 19.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,731 shares of the healthcare conglomerate’s stock after selling 2,796 shares during the period. UnitedHealth Group comprises approximately 0.8% of Coastline Trust Co’s investment portfolio, making the stock its 29th largest holding. Coastline Trust Co’s holdings in UnitedHealth Group were worth $6,859,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Tealwood Asset Management Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $2,905,000. Asset Planning Services Inc. LA ADV increased its position in shares of UnitedHealth Group by 1.2% in the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after buying an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC lifted its position in shares of UnitedHealth Group by 13.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock valued at $14,603,000 after buying an additional 3,006 shares in the last quarter. Americana Partners LLC raised its position in UnitedHealth Group by 10.8% during the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock worth $11,914,000 after acquiring an additional 1,984 shares during the period. Finally, Hennion & Walsh Asset Management Inc. grew its position in shares of UnitedHealth Group by 14.8% in the second quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock valued at $5,072,000 after purchasing an additional 1,283 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $592.18 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a 50 day moving average price of $582.84 and a 200 day moving average price of $549.06. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market capitalization of $544.97 billion, a P/E ratio of 38.58, a PEG ratio of 1.78 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the business posted $6.56 EPS. UnitedHealth Group’s revenue for the quarter was up 9.2% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on UNH shares. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Stephens decreased their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday. KeyCorp began coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Finally, HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.